
Align Technology (ALGN) Stock Forecast & Price Target
Align Technology (ALGN) Analyst Ratings
Bulls say
Align Technology is positioned well in a large and under-penetrated market with its dominant market share and a strong network of trained providers. The company's recent results have shown impressive breadth across geographies and channels, with strong demand for both its Invisalign clear aligners and iTero intraoral scanners. The company's management has set reasonable guidance for 2026, with expectations for continued growth and improved margins, giving investors increasing confidence in the stock's performance.
Bears say
Align Technology is heavily reliant on its Invisalign product, which controls over 90% of the clear aligner market. However, with an estimated 10% of all orthodontic cases treated by Invisalign in 2022 and a total of 14 million patients treated since launch, it is facing a saturated market. Additionally, the company's other product, iTero intraoral scanners, only capture a little over half of digital scans and face increasing competition from other digital scanning options, making it harder for them to maintain market dominance and sustain long-term growth.
This aggregate rating is based on analysts' research of Align Technology and is not a guaranteed prediction by Public.com or investment advice.
Align Technology (ALGN) Analyst Forecast & Price Prediction
Start investing in Align Technology (ALGN)
Order type
Buy in
Order amount
Est. shares
0 shares